Revance Announces Proposed Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. CDNS
3. SPY
4. META
5. ANT
6. JBLU
7. SSD
8. ARTV
9. AAPL
10. INTC

Go back to Revance Announces Proposed Public Offering of Common Stock

Revance Therapeutics (RVNC) Prices 5.34M Offering of Common Stock at $31/Share

December 7, 2017 8:34 AM EST

Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company developing botulinum toxin products for use in treating aesthetic and therapeutic conditions (Revance or the Company), today announced the pricing of an underwritten public offering of 5,338,709 shares of its common stock at a price to the public of $31.00 per share. In the offering, the Company will issue and sell 4,838,709 shares and certain stockholders of the Company (the Selling Stockholders) will sell 500,000 shares. Revance and the Selling Stockholders have granted the underwriters a 30-day option to purchase up to an... More